MAPK3 and non-small cell lung carcinoma: Previous studies have shown cardiac glycosides induces autophagic cell death in non-small cell lung cancer cells through multiple signaling pathways including mTOR deactivation, ERK1/2 activation [26], and JNK activation [27].